Most Read

  • RIP Molefi Thulo
    It is with profound sadness that we share the news that Molefi Thulo has passed away. This ever humble, always inspirational human will leave a massive hole in the industry that he loved so much, and to which he gave so much.
  • ADNA launches in Cape Town
    Creative intelligence group, ADNA (Audience DNA) is expanding into Africa with their new regional headquarters in Cape Town. The agency officially launched here in January this year with a full-service team including data, creative and strategic consultancy, consumer and market insights.
  • Nestlé Cremora remakes iconic 'it's not inside, it's on top' ad
    Much like its iconic advert 'it's not inside, it's on top' which portrayed an insightful observation of people's responses from all races, ages and genders; Nestlé Cremora, a local favourite coffee and tea creamer, remains an unforgettable brand, more so in light of its strong heritage with South African consumers.
  • Telkom announces a new CEO
    Telkom has announced that Serame Taukobong, the company's current CEO of the Telkom Consumer Business and a group executive committee member, has been appointed as its new group CEO, effective 1 October. Taukobong will take up the position on 1 July 2022.
  • #MarketingMasterminds: Saatchi & Saatchi creative director Stephanie Symonds on the nostalgia of Stimorol Retro
    This month's Marketing Mastermind is Stephanie Symonds, Saatchi & Saatchi creative director. She discusses Stimorol Retro. Issued by Facebook
  • Homegrown battery manufacturer secures R20m investment
    Boost for local champion bringing innovative, local and trusted battery storage solutions for African energy needs
    Issued by Edge Growth
Show more

Biovac to manufacture Pfizer Covid-19 vaccine for Africa

Biovac, a Cape Town-based biopharmaceutical company, has signed a letter of intent with Pfizer and BioNTech to manufacture the latter two companies' Covid-19 vaccine for distribution within the African Union.
Source: Biovac
Biovac will perform manufacturing and distribution activities within Pfizer’s and BioNTech’s global Covid-19 vaccine supply chain and manufacturing network, which will now span three continents and include more than 20 manufacturing facilities. To facilitate Biovac’s involvement in the process, technical transfer, on-site development and equipment installation activities will begin immediately.

Pfizer and BioNTech expect that Biovac’s Cape Town facility will be incorporated into the vaccine supply chain by the end of 2021. Biovac will obtain drug substance from facilities in Europe, and manufacturing of finished doses will commence in 2022. At full operational capacity, the annual production will exceed 100-million finished doses. All doses will exclusively be distributed within the 55 member states that make up the African Union.
Comment

Let's do Biz